Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease.

Petzold, A; Jenkins, R; Watt, H C; Green, A J E; Thompson, E J; Keir, G; Fox, N C; Rossor, M N

Petzold, A; Jenkins, R; Watt, H C; Green, A J E; Thompson, E J; Keir, G; Fox, N C; Rossor, M N.

Affiliation

Petzold A; Institute of Neurology, Department of Neuroinflammation, Queen Square, London WC1N 3BG, UK. a.petzold@ion.ucl.ac.uk

Neurosci Lett ; 336(3): 167-70, 2003 Jan 23.

Article in En | MEDLINE | ID: mdl-12505619

Subject(s)

Alzheimer Disease/cerebrospinal fluid; Brain/pathology; Nerve Growth Factors/adverse effects; Nerve Growth Factors/cerebrospinal fluid; S100 Proteins/adverse effects; S100 Proteins/cerebrospinal fluid; Adult; Aged; Alzheimer Disease/pathology; Atrophy; Dementia/cerebrospinal fluid; Enzyme-Linked Immunosorbent Assay; Female; Frontal Lobe/pathology; Humans; Male; Middle Aged; Nerve Growth Factors/metabolism; Nervous System Diseases/cerebrospinal fluid; Parietal Lobe/pathology; S100 Calcium Binding Protein beta Subunit; S100 Proteins/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Brain / S100 Proteins / Alzheimer Disease / Nerve Growth Factors Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neurosci Lett Year: 2003 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links